Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma

Pancreatic cancer is a molecularly heterogeneous disease. Epigenetic changes and epigenetic regulatory mechanisms underlie at least some of this heterogeneity and contribute to the evolution of aggressive tumor biology in patients and the tumor’s intrinsic resistance to therapy. Here we review our c...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Joyce K., Bednar, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715475/
https://www.ncbi.nlm.nih.gov/pubmed/34968245
http://dx.doi.org/10.3390/epigenomes5040020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715475/
https://www.ncbi.nlm.nih.gov/pubmed/34968245
http://dx.doi.org/10.3390/epigenomes5040020

Ejemplares similares